ascopubs.org: MammoSite partial breast irradiation following breast-conserving surgery for early-stage breast cancer. EurekAlert!: Radiation heart dose from MammoSite compared to IMRT for left-sided breast cancers When compared to IMRT, MammoSite Brachytherapy does not always deliver lower doses of radiation to the heart during treatment of left sided breast cancers. That is the finding of a study presented ...

Understanding the Context

Radiation heart dose from MammoSite compared to IMRT for left-sided breast cancers ascopubs.org: MammoSite brachytherapy for low-risk breast carcinoma: Toxicity, cosmetic evaluation and quality-of-life results of a phase II study MammoSite brachytherapy for low-risk breast carcinoma: Toxicity, cosmetic evaluation and quality-of-life results of a phase II study Business Wire: Proxima Therapeutics Receives FDA Clearance for Next Generation MammoSite Device; State-of-the-Art Catheters Will More Comfortably Deliver Targeted Internal Five-Day Radiation ... Proxima Therapeutics Receives FDA Clearance for Next Generation MammoSite Device; State-of-the-Art Catheters Will More Comfortably Deliver Targeted Internal Five-Day Radiation ... What is MammoSite? MammoSite is a type of brachytherapy, a form of radiation therapy in which a radioactive source is placed inside or next to the area requiring treatment rather than generally ...

Key Insights

Please provide your email address to receive an email when new articles are posted on . BOSTON — Results from a trial conducted by the American Society of Breast Surgeons and MammoSite showed that a ... Science Daily: Largest Single-institution Study Demonstrates Mammosite Is A Safe Breast Cancer Treatment Treating breast cancer with MammoSite® resulted in a low risk of complications and was generally well tolerated, according to a University of Pittsburgh study. The study, presented at the 47th annual ... The Business Journals: Proxima Therapeutics applies to FDA for MammoSite RTS breast cancer treatment